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Pax3 is a transcription factor expressed in the dorsal neural tube and somite of the developing embryo. It plays critical roles in pre-
migratory neural crest cells and in myogenic precursors of skeletal muscle. Pax3-deficient Splotch embryos display neural tube and neural
crest defects and lack hypaxial muscles. We have created a new allele of Splotch by replacing the first coding exon with a gene encoding Cre
recombinase. This functions as a null allele and no Pax3 protein is detected in homozygous embryos. Heterozygous Pax3Cre/+ mice display a
white belly spot, as do Splotch heterozygotes. Homozygous Pax3Cre/Cre embryos are embryonic lethal. We have used Pax3Cre/+ mice to fate-
map Pax3 derivatives in the developing mouse. As expected, neural crest and some somitic derivatives are identified. However, we also
detect previously unappreciated derivatives of Pax3-expressing precursors in the colonic epithelium of the hindgut and within the urogenital
system.
D 2005 Elsevier Inc. All rights reserved.
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Pax3 is a member of a small gene family characterized by
the presence of a conserved 120 amino acid paired-type
DNA binding domain (Chi and Epstein, 2002). Pax genes
are expressed by various organs and tissues in the de-
veloping embryo, and they play critical roles in cell fate
determination, survival, and proliferation of undifferentiated
cells. In general, Pax gene expression diminishes during late
stages of development in parallel with definitive differ-
entiation. The precise functions of Pax genes within various
precursor cell populations are the focus of ongoing studies,
and the cell types derived from specific Pax gene-expressing
precursors remain to be fully elucidated.
Pax3 is expressed by pre-migratory neural crest cells and
by presomitic mesoderm (Goulding et al., 1991). Expression0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: epsteinj@mail.med.upenn.edu (J.A. Epstein).initiates at ~E8.5 and becomes restricted to the dorsal neural
tube, where neural crest cells are specified, and to the
maturing somites. Neural crest cells represent a multipotent
population of migratory cells that give rise to the entire
peripheral nervous system, to melanocytes, enteric ganglia,
a subpopulation of vascular smooth muscle, bone, and
cartilage of the face, and to various other cell types. Pax3
plays a critical role during development of many neural crest
derivatives. A spontaneous mutation in Pax3 (Epstein et al.,
1993), which results in absent Pax3 protein expression (Li
et al., 1999), was identified in the 1950s because of a
melanocyte defect in heterozygous mice (Auerbach, 1954).
This phenotype accounts for the name bSplotchQ. Homo-
zygous Splotch mice on a C57BL/6 genetic background
display embryonic lethality by E14.5 due to cardiovascular
defects, and numerous neural crest derivatives are absent or
abnormal, including dorsal root ganglia, melanocytes, and
enteric ganglia (Auerbach, 1954; Epstein et al., 1993; Lang
et al., 2000). Severe neural tube defects are also present.
Several alleles of Splotch have been described, including280 (2005) 396–406
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(Epstein et al., 1993), and Sp2H, which is caused by an
intragenic deletion (Epstein et al., 1991). A hypomorphic
allele, Spd, caused by a missense mutation in the paired type
DNA binding domain, is characterized by a less severe
phenotype with homozygotes surviving until birth (Vogan
et al., 1993). Neural crest deficiencies and related cardio-
vascular defects are reported to be less severe than those
seen in loss-of-function alleles, while skeletal muscle
defects are similar (Franz, 1993).
Several reports have examined the effect of Pax3 loss-of-
function on neural crest migration and differentiation.
Although initial reports suggested that Pax3 is required for
proper neural crest migration (Conway et al., 1997a; Moase
and Trasler, 1990), more recent studies indicate that Pax3 is
not essential for migration. The absence of Pax3 may
influence survival, proliferation, or differentiation of neural
crest precursors and migrating neural crest cells which
accounts for neural crest-related defects (Conway et al.,
2000; Epstein et al., 2000). In Splotch embryos, cardiac
neural crest cells migrate to the outflow tract of the heart,
though outflow tract septation is deficient (Epstein et al.,
2000). Enteric ganglia precursors migrate to the foregut, but
c-ret expression is diminished and derivatives fail to
populate the mid and hindgut (Lang et al., 2000). It is not
clear if all neural crest derivatives are affected equally in the
absence of Pax3, or if certain lineages are favored at the
expense of others. Interestingly, facial derivatives of neural
crest are largely spared in Splotch homozygotes, perhaps
due to functional redundancy of the closely related Pax7
gene (Borycki et al., 1999; Jostes et al., 1990; Mansouri
et al., 1996). The complete repertoire of mature cell types
derived from Pax3-expressing embryonic precursors has not
been described.
Pax3 plays an important role in developing skeletal
muscle (Maroto et al., 1997; Tajbakhsh et al., 1997). In
particular, Pax3 is required for proper development of
hypaxial muscles, which derive from the lateral somite and
undergo long-range migration to the ventral body wall,
limbs, diaphragm, and tongue prior to differentiation
(Ordahl and Le Douarin, 1992). Although Pax3 is expressed
widely in the presomitic mesoderm, expression becomes
restricted to the hypaxial domain and, to a lesser extent, to
the most medial portions of the somite, during mid-
gestation. Migrating myoblasts initially continue to express
Pax3 and later down-regulate mRNA and protein expres-
sion as myogenic markers such as MyoD become apparent
(Daston et al., 1996; Tremblay et al., 1998; Williams and
Ordahl, 1994). Pax3 functions genetically upstream of
MyoD, since mice lacking MRF4, Myf5, and Pax3 fail to
express MyoD in any muscles below the neck (Kassar-
Duchossoy et al., 2004; Tajbakhsh et al., 1997). Pax3-
deficient embryos exhibit skeletal muscle defects and
transgenic rescue experiments have demonstrated an exqui-
site requirement for Pax3 during development of the
diaphragm and limb musculature (Li et al., 1999).Recently, we have described enhancer sequences
located in the upstream genomic region of the Pax3
gene that are sufficient to mediate dorsal neural tube and
neural crest expression in transgenic mice (Li et al.,
1999; Milewski et al., 2004). We have described trans-
genic mice in which the proximal 1.6 Kb of upstream
genomic sequence directs expression of Cre recombinase
(Li et al., 2000). Crosses with reporter mice indicate that
many neural crest derivatives below the neck are labeled
in mice carrying the Cre transgene and a Cre reporter.
However, some potentially ectopic expression was noted
in the lumbosacral region, and unexpected labeling of
derivatives not previously thought to derive from neural
crest, such as a small number of myocardial cells within
the heart, suggested that this transgene might be bleakyQ
and/or might express in cells that do not normally
express Pax3 (Li et al., 2000). In addition, significant
regions of the dorsal neural tube that normally express
Pax3 are not labeled by this transgene. Hence, we sought
to develop a more faithful Pax3-Cre mouse by gene
targeting. Here, we report successful targeting of Cre
recombinase to the Pax3 locus, and we demonstrate both
expected and unexpected derivatives of Pax3-expressing
precursors.Materials and methods
Generation of Pax3Cre/+ mice
The targeting vector backbone was based on the pPNT
vector (Tybulewicz et al., 1991) modified to include a LoxP
flanked PGK-neo cassette and a PGK-HSV thymidine
kinase gene. The 5V arm was 6.2 kb of the murine Pax3
upstream genomic sequence fused with Cre and a bovine
growth hormone polyadenylation site (derived from Li
et al., 2000), a LoxP flanked PGK-neo cassette and 1.4 kb of
Pax3 3Vflanking sequence derived from intron 1. Most of the
first Pax3 exon downstream of the transcription start site
including the initiating ATG and 69 5Vflanking nucleotides
was replaced.
The Pax3CreKI targeting vector was linearized by
digestion with AscI and electroporated into 2  107 R1
embryonic stem (ES) cells (Nagy et al., 1993) in a 0.4-mm
cuvette at 300 V for 1 ms using a BTX electro cell
manipulator. Five targeted clones out of 350 were identified
by PCR and DNA from three of these PCR-positive ES cell
clones was analyzed by Southern blotting using a 3V
flanking probe. One of three ES cell clones positive for
homologous recombination by both PCR and Southern
blotting was injected into C57BL/6J mouse embryos. Five
(129/Sv  C57BL/6J) chimeras were generated. The
Pax3Cre allele was maintained on a mixed 129/Sv 
C57BL/6J genetic background. After passing through the
male germline, the PGK-neo cassette was no longer present
within the targeted locus.
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by PCR analysis (948C, 5 min; 35 cycles of 948C, 1 min
denaturing; 658C, 1 min annealing; 728C, 1 min extension;
728C, 5 min final extension) using the following primers:
5V-CTG CAC TCG GTG TCA CG-3V
5V-AAG CGA GCA CAG TGC GGC-3V
5V-GAA ACA GCA TTG CTG TCA CTT GGT CGT
GGC-3V
The institutional animal care and use committee of the
University of Pennsylvania approved all animal protocols.
In situ hybridization
The radioactive antisense riboprobe used for Pax3 in situ
hybridization was transcribed using T7 RNA polymerase
from HindIII-digested template DNA. This template is
pBH3.2 containing mouse Pax3 cDNA (Goulding et al.,
1991) modified by removal of an internal SmaI fragment.
The probe will detect the 5V end of the transcripts arising
from both the endogenous and the targeted mouse Pax3
loci. Detailed in situ protocols are available at http://
www.uphs.upenn.edu/mcrc.
Immunohistochemistry and immunoblotting
Antibodies used included rabbit polyclonal anti-Pax3 (Li
et al., 1999), rabbit anti-tyrosine hydroxyalase (Chemicon),
mouse monoclonal anti-Pax3 (Venters et al., 2004), mouse
monoclonal anti-neurofilament (2H3), rabbit polyconal anti-
h-galactosidase (Cortex Biochem), anti-tubulin (Ab-1,
Oncogene Research Products) and mouse monoclonal
anti-PGP 9.5 (clone 10A1, Research Diagnostics, Inc.).
The monoclonal anti-Pax3 and anti-neurofilament anti-
bodies were obtained from the Developmental Studies
Hybridoma Bank (Department of Biological Sciences,
University of Iowa). The murine anti-Pax3 monoclonal
antibody (Venters et al., 2004) was prepared against carboxy
terminal amino acids #298–481 of quail Pax3 (GenBank
accession #AF000673). This partially overlaps the rabbit
anti-Pax3 polyclonal antibody epitope (Li et al., 1999) to the
carboxy terminal 120 amino acids of murine Pax3 (Gen-
Bank accession #X59358). The anti-Pax3 immunoblot was
prepared using total embryonic cell lysates and the murine
anti-Pax3 antibody (Venters et al., 2004). Protocols are
available at http://www.uphs.upenn.edu/mcrc.Results
Generation of Pax3 Cre knockin mice
In order to create mice in which Cre recombinase is
expressed by all cells that normally expressPax3, we targeted
the endogenous Pax3 locus by inserting a cDNA encodingCre recombinase into the first exon of Pax3 using homolo-
gous recombination in embryonic stem cells (Fig. 1A). We
replaced the initiating ATG codon ofPax3 and the majority of
the first exon with the Cre cDNA and a floxed PGK-neo
cassette. This strategy is predicted to disrupt endogenous
Pax3 expression. Correctly targeted ES cells were identified
by Southern blotting (Fig. 1B) and used to create chimeric
mice and to obtain germline transmission of the targeted locus
(Fig. 1C).
Heterozygous Pax3Cre/+ mice appeared healthy and were
fertile. These mice were maintained on a mixed C57BL/6
and sv129 genetic background and displayed an agouti or
black coat color. In approximately 50% of cases, a clearly
demarcated white belly spot was evident (Fig. 1D), similar
to that seen in Splotch heterozygotes (Auerbach, 1954)
suggesting a mild melanocyte defect.
Matings of heterozygous Pax3Cre/+ mice failed to
produce cre homozygous offspring (Table 1). However,
we identified some late gestation (E18.5) embryos that were
already resorbing, indicating pre-natal lethality. Therefore,
we examined embryos derived from timed matings of
heterozygous mice to determine the cause and timing of
embryonic lethality. At E13.5, we observed homozygous
embryos with severe neural tube defects including exence-
phaly and rachischisis (Fig. 1E). In several cases, cardiac
outflow tract septation was deficient and examples of
double outlet right ventricle and persistent truncus arteriosus
with ventricular septal defect were present (Figs. 1F–I). The
ventricular myocardium was thinned. Histologic examina-
tion revealed absent limb musculature (Figs. 1J, K) and
small or absent dorsal root ganglia (Figs. 1L, M). This
constellation of findings is similar to that seen in homo-
zygous Splotch embryos.
At E17.5, we identified Pax3Cre/Cre embryos that always
displayed severe neural tube defects and absent limb
musculature. On a C57BL/6 background, Splotch homo-
zygosity is uniformly lethal by E14.5, though we have noted
survival until later stages of embryogenesis on mixed
genetic backgrounds (JAE, unpublished observations). In
late surviving Pax3Cre/Cre embryos, we usually observed a
properly septated cardiac outflow tract, suggesting that less
severe cardiac defects correlated with prolonged embryonic
survival.
Pax3Cre/Cre embryos display loss of Pax3 protein expression
In order to determine if the targeted Pax3 locus
represents a null allele of Pax3, we examined Pax3 RNA
and protein expression at E12.5 in wild type and Pax3Cre/Cre
embryos. First, we examined mRNA expression by in situ
hybridization using a probe that detects both wild type and
targeted loci. Expression was similar in wild type and
Pax3Cre/Cre embryos (Figs. 2A, B). We utilized two distinct
Pax3 antibodies, both directed against C-terminal regions of
the protein (Li et al., 1999; Venters et al., 2004) to determine
if Pax3 protein expression was affected. Our targeting
Fig. 1. (A) Targeting strategy for replacement of Pax3 exon 1 with Cre. (B) Southern blot of wild type (+/+) and 3 targeted ES cell clones (+/Cre). (C) PCR
results confirming genotype of wild type, heterozygous (+/Cre) and homozygous (Cre/Cre) mice. (D) White belly spot present on 2 heterozygous mice. (E)
Neural tube defect (arrow) in E13.5 homozygous embryos (Cre/Cre). (F–I) Cross sections of hearts of wild type (F, H) and Cre/Cre (G, I) embryos showing
persistent truncus arteriosus (PTA, arrow) in Cre/Cre (G) and ventricular septal defect (VSD, arrow) (I). (J–M) Cross section of E18.5 wild type (J, L) and Cre/
Cre (K, M) embryos showing absent limb muscles in Cre/Cre (K) and absent dorsal root ganglia (arrows, M). PA, pulmonary artery; Ao, aorta; lb, limb bud; nt,
neural tube.
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alternative start sites or alternative splicing could have
potentially resulted in the production of Pax3 peptides with
partial or complete function. However, we did not detect any
evidence of Pax3 protein expression using either mouse
monoclonal or rabbit polyclonal antibodies (Figs. 2C–F).
Immunoblotting of total tissue lysates from E11.5 embryos
demonstrated a decrease of approximately half of wild type
Pax3 protein expression in heterozygous embryos and
complete loss of detectable Pax3 protein in homozygous
targeted embryos (Fig. 2G). These results, combined with
the phenotype of Pax3Cre/Cre embryos that closely resem-
bles that of Splotch embryos, indicate that our targeting
strategy has resulted in a null allele of Pax3.Table 1
Genotype of offspring from Cre/+ heterozygous intercrosses
Genotype E12.5–13.5 E14.5–18.5 P0
+/+ 10 56 68
Cre/+ 16 87 117
Cre/Cre 10 33 0Efficient recombination produced by Pax3Cre/+ mice
We crossed Pax3Cre/+ mice with Z/EG reporter mice to
determine if Cre expression would mediate efficient
recombination of DNA and subsequent expression of
green fluorescent protein (GFP) (Novak et al., 2000). We
also utilized R26R reporter mice in which Cre-mediated
recombination results in expression of h-galactosidase
activity (Soriano, 1999). We examined offspring of
Pax3Cre/+ and Cre reporter crosses at various time points
during gestation and after birth. As expected, reporter gene
activity was detected in the dorsal neural tube and in the
somites of E9 and E11.5 embryos (Figs. 3A, B). At E11.5,
cardiac neural crest cells contributing to the outflow tract
of the heart (Figs. 3C, D) were easily identified after
explanting and sectioning the heart. These show a pattern
of labeled cells consistent with the known neural crest
contribution as determined by previous fate-mapping
approaches (Jiang et al., 2000; Li et al., 2000; Pietri
et al., 2003). Although neural crest contribution to
the cardiac myocardium has been reported in zebrafish
Fig. 2. (A, B) In situ hybridization of cross sections of E12.5 wild type (A)
and Cre/Cre (B) embryos reveals mRNA expression of wild type and
targeted alleles in dorsal neural tube. (C–F) Immunohistochemistry with
rabbit polyclonal Pax3 antibody (C, D) or mouse monoclonal Pax3
antibody (E, F) reveals absent Pax3 protein in Cre/Cre embryos (D, F)
compared to wild type (C, E). Neurofilament staining is shown as a positive
control (insets, C, D). (G) Immunoblot analysis of E11.5 total embryonic
lysates using murine monoclonal Pax3 antibody indicates reduced Pax3
protein expression in heterozygous Cre/+ embryos and absent Pax3 protein
expression in homozygous Cre/Cre embryos compared to wild type (+/+).
The first lane shows Pax3 protein expression from C2C12 cells transfected
with a Pax3 expression plasmid as control. Tubulin expression is similar in
embryonic samples indicating equal loading.
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to epicardium have been proposed to occur in mice
(Stottmann et al., 2004), we never saw any specific label-
ing of cells in myocardium or epicardium of heterozygous
or homozygous Pax3Cre mice. By E15.5, various neural
crest and somite derivatives were also labeled, including the
dorsal root ganglia, and skeletal muscles (Fig. 3E).
Labeled cells were grossly apparent in the explanted
hearts at E13.5 (Fig. 3F). By late gestation (E18.5),
extensive contributions to the ductus arteriosus and aortic
arch were evident (Fig. 3G). Skeletal muscle in the limbs
was uniformly labeled (Fig. 3H). At E18.5, the diaphragm
and other skeletal muscles were labeled, as were the
enteric ganglia and the adrenal medulla (Fig. 3I). Surpris-ingly, we also noted extensive expression in renal
parenchyma (see below). The observed Cre-mediated
recombination of reporter genes recapitulated Pax3 pro-
tein expression as indicated by coincident staining of
h-galactosidase and Pax3 protein in Pax3Cre/+, R26R
embryos (Figs. 3J–L).
Derivatives of Pax3-expressing cells contribute to the
urogenital system
Closer analysis of Pax3Cre/+, R26R mice revealed an
extensive contribution of labeled cells to the genitourinary
tract. Within the kidney, h-galactosidase-expressing cells
were identified throughout the kidney (Figs. 4A, B).
Specifically labeled cells were never identified in the
kidneys of R26R mice that did not express Cre. Pax3-
derived cells included derivatives of the metanephrogenic
mesenchyme such as glomerular epithelia, mesenchyme,
and some tubular epithelia (Figs. 4C–E). Tubular epithelia
of the collecting system were not labeled, though some
h-galactosidase-expressing cells were identified in the
ureters (Fig. 4F). This pattern of expression is similar to
that reported previously for P3proCre mice (Chang et al.,
2004). h-galactosidase-expressing cells were also noted in
regions of the male genital system, including the vas
deferens and epididymis (Fig. 4G). Genitourinary tissue
expressing h-galactosidase was first noted at E11.5 when
rare cells in the loose mesenchyme surrounding the
ureteric bud were identified by X-gal staining. Some of
these cells co-expressed Pax3 protein (Figs. 4H–K). At
E12.5, E15.5, and E18.5, Pax3 protein was not detected
in the kidney.
Pax3-expressing cells give rise to some colonic epithelia
We examined the intestines of Pax3Cre/+, R26R embryos
in detail since Pax3-expressing neural crest precursors are
known to give rise to the enteric ganglia (Figs. 5A–E).
Labeled cells were identified in the intestinal walls at all
levels, and these co-stained with an antibody directed
against neurofilament (inset, Fig. 5D) consistent with their
identification as enteric ganglia. In addition to this expected
expression domain, we noted intense regions of h-galacto-
sidase expression in the region of the terminal hindgut of
Pax3Cre/+, R26R embryos which was not apparent in control
litter mates (Figs. 5B, C, arrows). Serial sections of these
specimens revealed significant numbers of colonic epithelial
cells that were derived from Pax3-expressing precursors
(Figs. 5E–G), while we never saw any evidence of specific
h-galactosidase expression in R26R mice that did not carry
the Pax3Cre/+ allele. We rarely identified h-galactosidase
expression by intestinal epithelia proximal to the ileo-cecal
junction, and we did not identify labeling of other
endodermal derivatives including the pancreas, liver, spleen,
or airway epithelia. Expression of h-galactosidase in
unexpected domains including distal colonic epithelium
Fig. 3. (A) E9 Pax3Cre/+, Z/EG embryo reveals Pax3 derivatives (green) in dorsal neural tube, somites, and facial structures. (B) E11.5 Pax3Cre/+, R26R
embryo reveals Pax3 derivatives (blue) in dorsal neural tube, somites, and facial structures. (C) E11.5 Pax3Cre/+, R26R heart showing labeled (blue) Pax3
derivatives (arrows) in the conotruncal endocardial cushions. (D) E11.5 Pax3Cre/+, R26R heart showing labeled (blue) Pax3 derivatives (arrow) in the
conotruncal cushions in a section caudal to that shown in panel C. Note the absence of labeled cells in the atrioventricular (av) cushions or in the myocardium
of the left atrium (la) or ventricle. (E) E15.5 Pax3Cre/+, Z/EG embryo shows labeled Pax3 derivatives (green) in limb muscle and facial structures. (F) Heart
from E13.5 Pax3Cre/+, Z/EG embryo reveals Pax3 derivatives (green) in the outflow tract. (G) Heart from E18.5 Pax3Cre/+, R26R embryo reveals Pax3
derivatives (blue) in the ductus arteriosus and aortic arch (AoA) but not in the descending aorta (dAo). (H) Pax3 derivatives (blue) in an E14.5 Pax3Cre/+, R26R
limb (lb). (I) Sagittal section of an E18.5 Pax3Cre/+, R26R embryo (caudal is bottom, cranial is top) reveals Pax3 derivatives (blue) in aorta (Ao), diaphragm
(d), adrenal medulla (ad), kidney (ki), and enteric ganglia (eg) but not in liver (li) or heart (ht). (J) Labeled Pax3 derivatives (blue) in E11.5 Pax3Cre/+, R26R
somites. (K) Immunohistochemical analysis with monoclonal Pax3 antibody (green) of section shown in panel J. (L) Merged image of panels J and K. ra, right
atrium; lv, left ventricle; rv, right ventricle.
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galactosidase antibodies and enzymatic detection methods
and by using alternative Cre reporter mice (not shown).
Colonic epithelia expressing h-galactosidase were first
noted at E11.5. At later time points, labeled cells included
both goblet cells and absorptive enterocytes, cell types
known to arise from common precursors that reside within
intestinal crypts. Since Pax3-expressing cells were not
detected by in situ hybridization or immunohistochemistry
in colonic epithelium of E9.5 or older wild type embryos(data not shown), the labeled cells appear descended from
Pax3-expressing ancestors or from rare progenitors, but the
specific Pax3-expressing precursor cell has not been
identified. As shown in Figs. 5F and G, we observed entire
villi that were labeled, and we often observed several
adjacent labeled villi, consistent with the concept of bcrypt
fissionQ as a mechanism of growth of colonic epithelium
(Kim and Shibata, 2004). These results suggest that Pax3 is
expressed by precursors of some colonic epithelial cells and
perhaps by some colonic epithelial stem cells.
Fig. 4. (A) Wild type kidneys (ki) from a newborn mouse do not stain for h-galactosidase expression. (B) Kidneys from a Pax3Cre/+, R26R newborn mouse
express extensive h-galactosidase (blue) expression. The adrenal medulla (ad, arrow) is also stained. (C) E16.5 Pax3Cre/+, R26R kidney reveals extensive
mesenchymal expression (blue). (D) Adult Pax3Cre/+, R26R kidney reveals expression in glomeruli and some tubules (blue). (E) Mesenchymal h-galactosidase
(blue) expression in a Pax3Cre/+, R26R newborn glomerulus and tubule. (F) Ureteral h-galactosidase expression (blue) in an adult Pax3Cre/+, R26R mouse. (G)
Adult Pax3Cre/+, R26R testes (unstained) with associated epididymis stained for h-galactosidase (blue). (H) E11.5 Pax3Cre/+, R26R embryo showing the
location of the ureteric buds (ub, arrows). (I) Higher-powered view of the boxed region of panel H showing mesenchymal cells stained for h-galactosidase
(blue). (J) Immunohistochemical analysis with monoclonal Pax3 antibody (green) of section shown in panel I. (K) Merged image of panels I and J showing
colocalization of labeled Pax3 derivatives (blue) expressing Pax3 protein (green).
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We compared the fate of Pax3-expressing precursors in
embryos that expressed Pax3 and in those that lacked
functional Pax3 protein. Pax3Cre/Cre, R26R embryos on the
mixed genetic background used here do not express Pax3
and sometimes survive until late gestation, thus allowing for
analysis of Pax3 descendants at developmental stages
beyond which homozygous Splotch embryos can be readilyexamined. Consistent with earlier reports, we found a
significant reduction in the size and labeling of peripheral
ganglia (Figs. 2C, D insets, and data not shown). Pax3-
descendents contributed to a septated heart and great vessels
of both heterozygous (Figs. 6A, C) and homozygous (Figs.
6B, D) embryos, though staining was less intense in
homozygous specimens. As expected, the diaphragm was
not muscularized in homozygous embryos compared to
controls (Figs. 6E, F) and Pax3-descendents were not
Fig. 5. (A) Wild type and Pax3Cre/+, R26R newborn gut reveals h-galactosidase (blue) expression only in Pax3Cre/+, R26R samples. (B) Wild type intestine.
(C) Pax3Cre/+, R26R intestine. Note intense staining in distal hindgut (arrows). (D) Section of adult intestine from Pax3Cre/+, R26R gut indicates labeled enteric
ganglia (eg). Inset shows enteric ganglia region costained with antibodies to h-galactosidase (green) and neurofilament (2H3, red). (E) E13.5 Pax3Cre/+, R26R
embryo reveals h-galactosidase expression in enteric ganglia (eg) and enteric epithelium (ep). (F) Intestinal epithelium from adult Pax3Cre/+, R26R mouse
indicates groups of adjacent villi with intense staining. (G) Higher-power image of panel F.
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crest derivatives in the adrenal medulla, marked by
expression of tyrosine hydroxylase, were greatly dimin-
ished, but not completely absent, in Pax3Cre/Cre embryos,
consistent with a reduction (but not total elimination) of
differentiated neural crest tissues (Figs. 6G, H). Enteric
ganglia were markedly reduced in homozygous specimens,
especially in the distal portions of the intestines (Figs. 6I–L).
However, colonic epithelia expressing h-galactosidase in
the distal hindgut were present in embryos lacking Pax3
expression (Fig. 6L), as were mesenchymal derivatives of
the urogenital system (not shown).Discussion
We have generated a mouse in which the Pax3 locus has
been re-engineered such that Pax3 expression is replaced
with that of Cre recombinase. The results obtained from
analysis of homozygous targeted embryos and from hetero-zygous mice carrying a Cre-reporter allele clarify several
controversies that have arisen from prior studies and identify
previously unappreciated cell types derived from Pax3-
expressing precursors.
Previous work from our laboratory has utilized transgenic
approaches to express Cre recombinase in Pax3-expressing
neural crest cells (Li et al., 2000). Transgenic P3proCre mice
express Cre recombinase in the dorsal neural tube, though
expression differs from that of endogenous Pax3. The
transgene is not expressed in large regions of the central
nervous system and the hindbrain where Pax3 is normally
expressed. Moreover, mesodermal expression lateral to the
neural tube in the lumbo-sacral region occurs in a relatively
broad domain and has been useful for manipulating gene
expression in the mesenchyme of the urinary tract (Chang et
al., 2004), though it was unclear if this domain represented
ectopic expression. Fate-mapping studies using P3proCre
and R26R reporter mice (Li et al., 1999), or a similar
approach using a transgenic Cre recombinase driven by a
tissue plasminogen activator promoter to mark neural crest
Fig. 6. (A) E18.5 heart from a Pax3Cre/+, R26R embryo reveals Pax3-descendents (blue) in the cardiac outflow tract (arrow). (B) E18.5 heart from a
Pax3Cre/Cre, R26R litter mate displays reduced intensity of h-galactosidase expression (blue) in the cardiac outflow tract. (C) Section of an E18.5 Pax3Cre/+,
R26R heart showing h-galactosidase (blue) staining in the aorta (Ao) and outflow tract region (arrow). (D) Comparable section of an E18.5 Pax3Cre/Cre,
R26R heart showing h-galactosidase (blue) staining in the aorta (Ao) and outflow tract region (arrow). (E) Sagittal section of an E18.5 wild type embryo.
The diaphragm (arrow, d) is muscularized. (F) The diaphragm of a homozygous Pax3Cre/Cre littermate is thinned and without evidence of muscularization.
(G, H) Immunohistochemical analysis for the neuronal marker tyrosine hydroxylase in the medullary region (arrows) of adrenal glands from wild type (G)
and Pax3Cre/Cre (H) E16.5 embryos. (I, J) PGP9.5 antibody (recognizing neurons) staining of wild type (I) and Pax3Cre/Cre (J) E18.5 embryo intestines
reveals reduction of enteric ganglia (eg) in mutant sample. (K, L) Intestines from Pax3Cre/+, R26R (K) and Pax3Cre/Cre, R26R (L) E18.5 embryos stained
for h-galactosidase expression reveals reduced enteric ganglia (eg) in homozygous mutants but persistent expression in intestinal epithelia (ep). li, liver; lv,
left ventricle.
K.A. Engleka et al. / Developmental Biology 280 (2005) 396–406404cells (Pietri et al., 2003), or Wnt1-Cre mice (Jiang et al.,
2000), identified neural crest derivatives contributing to the
cardiovascular system. Smooth muscle cells of the aortic
arch and head vessels were labeled, as were a variable
number of myocardial cells within the walls of the ventricles
(Li et al., 1999). Since neural crest cells are thought to give
rise to some myocardial components in zebrafish, these
results raised the possibility that Pax3-expressing neural
crest precursors might occasionally give rise to myocardial
cells in mammals. On the other hand, distinct neural crest-
restricted Cre mice have been used for similar fate-mapping
studies leading to the speculation that neural crest might give
rise to occasional epicardial cells composing the outer layer
of the heart (Stottmann et al., 2004).
By inserting Cre into the endogenous Pax3 locus, it is
extremely unlikely that there is any ectopic expression of
Cre recombinase. This obviates a major concern of the priortransgenic approaches. Hence, all labeled cells in the present
experiments can be considered derivatives of Pax3-express-
ing precursors, though the precise cell of origin (neural
crest, somite, or other) cannot be determined. The lack of
labeled Pax3-derivatives in the myocardium, the coronary
arteries and the epicardium of the heart conclusively
demonstrates that Pax3-expressing neural crest precursors
do not give rise to these structures, strongly arguing that
they are not of neural crest origin.
Pax3Cre/+ mice will prove to be useful for further fate-
mapping studies and tissue-specific inactivation of genes in
the neural crest and somite lineages. However, one caveat of
the strategy that we adopted is that endogenous Pax3
expression is simultaneously disrupted, such that fate-
mapping studies and potential future gene inactivation
studies are performed on a heterozygous Pax3-deficient
genetic background. Furthermore, we show that Pax3Cre/+
K.A. Engleka et al. / Developmental Biology 280 (2005) 396–406 405mice express about half of the wild type levels of Pax3
protein, and a haploinsufficient phenotype is evident, at
least in melanocytes.
Another important caveat for the use of Pax3Cre/+ mice
to mediate tissue-specific genomic recombination is that we
occasionally saw ubiquitous h-galactosidase expression in
offspring of male mice carrying both Pax3Cre/+ and R26R
alleles consistent with expression in the male germline or
early embryos. Hence, future experiments designed to
inactivate genes in specific Pax3 derivatives such as neural
crest or skeletal muscle should be performed such that the
Pax3Cre/+ and floxed alleles are derived from separate
parents to avoid ubiquitous recombination.
Homozygous loss of Pax3 expression in Pax3Cre/Cre
mice, at least on the mixed 129/Sv  C57BL/6J background
that we used, is not uniformly lethal until late gestation. This
result is somewhat surprising given that homozygous
Splotch embryos on a C57Bl/6 background are uniformly
lethal by E14.5. The difference is likely due to genetic
modifiers and is consistent with our prior observations and
with variable embryonic lethality reported for the Sp2H
allele when bred on mixed genetic backgrounds (Conway
et al., 1997b; Epstein et al., 1991). Our results are in
agreement with the prior work of Conway et al. (1997b)
who showed a correlation between conotruncal heart defects
and mid-gestation lethality.
In this report, we used the Pax3Cre/+ mice with Cre reporter
lines to obtain fate-mapping results that delineate both
expected and novel Pax3 descendents. Previously, transgenic
expression of Cre recombinase in P3proCre mice was used to
inactivate calcineurin function in urogenital tissue derived
from metanephrogenic mesenchyme to produce a mouse
model of congenital obstructive nephropathy (Chang et al.,
2004). The expression of Cre in this domain was identified
fortuitously and was unexpected. Our results using Pax3Cre/+
mice verify that mesenchymal components of the urogenital
system derive from Pax3-expressing precursors. Surpris-
ingly, fate mapping with Pax3Cre/+ mice also identified some
colonic epithelia as descendents of Pax3-expressing cells.
These results suggest a broader diversity of Pax3-descen-
dents than previously appreciated.Acknowledgments
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